Home
Viroclinics Biosciences

Viroclinics Biosciences Market Share Analysis for June 2026

Explore career opportunities at Cerba Research and join our innovative team.

Industry: N/A

Domainviroclinics.com

Year Founded2001

Employees201 - 500

Annual Revenue$15M - $25M

Viroclinics Biosciences

Viroclinics Biosciences (including company regionals)

viroclinics.com

See more website traffic and engagement information

Viroclinics Biosciences Revenue up to June 2026 is 15M - 25M

revenue generated by Viroclinics Biosciences top domains

Viroclinics Biosciences top domains revenue over 3 years

Revenue for Viroclinics Biosciences top domains

viroclinics.com15M - 25M

See more with Sales Intelligence

Total visits to Viroclinics Biosciences's top domains

Understand Viroclinics Biosciences market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

viroclinics.com928

See more with Sales Intelligence

Avg. visit duration in Viroclinics Biosciences's top domains

Analyze Viroclinics Biosciences engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

viroclinics.com--

See more with Sales Intelligence

Avg. pageviews on Viroclinics Biosciences's top domains

See how Viroclinics Biosciences keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

viroclinics.com1.06

See more with Sales Intelligence

Viroclinics Biosciences top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Viroclinics Biosciences

These are the website technologies, by industry, used by Viroclinics Biosciences top domains

Advertising (4)

PubMatic

Widget (3)

Twemoji

Conversion & Analytics (2)

Google Analytics

Email Services (2)

Microsoft Exchange Online

More Technologies

10

See all

News & Signals from Viroclinics Biosciences

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCerba HealthCare Group acquired Viroclinics on Jul 1st '22.In July 2022, Cerba Healthcare entered an agreement to acquire Viroclinics-DDL to strengthen its position in the entire value chain of diagnosis and stresses the pivotal role of clinical trial services.

NewsMolho left Viroclinics as CEO on Jan 1st '20.Dr. Molho joins Summit Partners’ EIR program from Viroclinics-DDL, a Summit-backed virology and immunology CRO, where he had served as CEO since 2020.

NewsCerba Xpert partnered with Viroclinics on Feb 17th '22.On February 17, 2022, Viroclinics-DDL, declared that Cerba Research, had collaborated with Viroclinics-DDL, contract research organization.